Johnson & Johnson (JNJ)
156.76
-1.42
(-0.90%)
USD |
NYSE |
Mar 18, 16:00
156.86
+0.10
(+0.06%)
Pre-Market: 05:03
Johnson & Johnson Shareholders Equity (Quarterly): 68.77B for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 68.77B |
September 30, 2023 | 71.23B |
June 30, 2023 | 75.15B |
March 31, 2023 | 70.87B |
December 31, 2022 | 76.80B |
September 30, 2022 | 74.60B |
June 30, 2022 | 76.36B |
March 31, 2022 | 74.71B |
December 31, 2021 | 74.02B |
September 30, 2021 | 70.27B |
June 30, 2021 | 69.58B |
March 31, 2021 | 65.83B |
December 31, 2020 | 63.28B |
September 30, 2020 | 64.47B |
June 30, 2020 | 62.98B |
March 31, 2020 | 61.29B |
December 31, 2019 | 59.47B |
September 30, 2019 | 58.21B |
June 30, 2019 | 60.78B |
March 31, 2019 | 58.96B |
December 31, 2018 | 59.75B |
September 30, 2018 | 64.63B |
June 30, 2018 | 62.89B |
March 31, 2018 | 63.26B |
December 31, 2017 | 60.16B |
Date | Value |
---|---|
September 30, 2017 | 73.98B |
June 30, 2017 | 71.92B |
March 31, 2017 | 70.34B |
December 31, 2016 | 70.42B |
September 30, 2016 | 72.77B |
June 30, 2016 | 72.47B |
March 31, 2016 | 72.65B |
December 31, 2015 | 71.15B |
September 30, 2015 | 71.55B |
June 30, 2015 | 71.13B |
March 31, 2015 | 67.88B |
December 31, 2014 | 69.75B |
September 30, 2014 | 76.59B |
June 30, 2014 | 78.05B |
March 31, 2014 | 76.58B |
December 31, 2013 | 74.05B |
September 30, 2013 | 69.80B |
June 30, 2013 | 69.66B |
March 31, 2013 | 66.86B |
December 31, 2012 | 64.83B |
September 30, 2012 | 63.76B |
June 30, 2012 | 60.43B |
March 31, 2012 | 61.37B |
December 31, 2011 | 57.08B |
September 30, 2011 | 61.53B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
58.21B
Minimum
Sep 2019
76.80B
Maximum
Dec 2022
67.88B
Average
69.18B
Median
Shareholders Equity (Quarterly) Benchmarks
Amgen Inc | 6.232B |
Gilead Sciences Inc | 22.83B |
Eli Lilly and Co | 10.77B |
Merck & Co Inc | 37.58B |
Moderna Inc | 13.85B |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 167.56B |
Total Liabilities (Quarterly) | 98.78B |
Debt to Equity Ratio | 0.4265 |
Current Ratio | 1.156 |
Net Debt Paydown Yield | 0.14% |